Innophos Holdings, Inc. (NASDAQ:IPHS) declared a quarterly dividend on Friday, November 2nd, Wall Street Journal reports. Stockholders of record on Friday, November 16th will be paid a dividend of 0.48 per share by the specialty chemicals company on Friday, December 7th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 6.26%. The ex-dividend date of this dividend is Thursday, November 15th.
Innophos has increased its dividend payment by an average of 2.9% per year over the last three years. Innophos has a dividend payout ratio of 68.8% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Innophos to earn $2.65 per share next year, which means the company should continue to be able to cover its $1.92 annual dividend with an expected future payout ratio of 72.5%.
Shares of NASDAQ IPHS traded down $0.30 during trading hours on Friday, reaching $30.65. 186,509 shares of the stock were exchanged, compared to its average volume of 109,576. The firm has a market cap of $586.10 million, a P/E ratio of 12.47 and a beta of 0.70. The company has a current ratio of 2.75, a quick ratio of 1.34 and a debt-to-equity ratio of 0.99. Innophos has a 52 week low of $27.46 and a 52 week high of $50.40.
Innophos (NASDAQ:IPHS) last announced its earnings results on Thursday, November 1st. The specialty chemicals company reported $0.58 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.59 by ($0.01). The firm had revenue of $196.93 million for the quarter, compared to the consensus estimate of $197.20 million. Innophos had a return on equity of 14.28% and a net margin of 2.21%. Innophos’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter last year, the business posted $0.78 EPS. Analysts forecast that Innophos will post 2.35 EPS for the current year.
A number of equities research analysts have weighed in on IPHS shares. BidaskClub downgraded Innophos from a “buy” rating to a “hold” rating in a report on Wednesday, July 25th. Zacks Investment Research downgraded Innophos from a “buy” rating to a “hold” rating in a report on Thursday, July 5th. TheStreet downgraded Innophos from a “b-” rating to a “c+” rating in a report on Thursday, August 23rd. Finally, ValuEngine downgraded Innophos from a “hold” rating to a “sell” rating in a report on Friday, October 12th.
Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.
Featured Story: How much money do you need to begin day trading?
Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.